Francesca Barone
Net worth: 1 M $ as of 31/08/2026
Net worth: 1 M $ as of 31/08/2026
Francesca Barone is currently Chief Scientific Officer at Candel Therapeutics, Inc. since 2022.
Former positions include Director-Laboratories at the Institute of Translational Medicine, Associate Professor at the University of Birmingham from 2010 to 2019, and Head-Experimental Medicine at Senda Biosciences, Inc. from 2019 to 2021.
Education includes doctorates from Sapienza University of Rome and King's College London.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 29/06/2026 | 77,362 ( 0.1% ) | 1 M $ | 31/08/2026 |
| Companies | Position | Start |
|---|---|---|
| CANDEL THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/11/2020 |
| Companies | Position | End |
|---|---|---|
Senda Biosciences, Inc.
Senda Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics to treat diseases | Corporate Officer/Principal | 01/11/2021 |
University of Birmingham
University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/12/2019 |
Institute of Translational Medicine | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
University of Birmingham
University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sapienza University of Rome
Sapienza University of Rome Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
King's College London
King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Candel Therapeutics, Inc.
Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
Senda Biosciences, Inc.
Senda Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics to treat diseases | Health Technology |
Institute of Translational Medicine |
Select your edition
All financial news and data tailored to specific country editions